NCT Number: NCT00006382
Lung Screening Study
RATIONALE: New imaging procedures such as spiral CT may improve the ability to detect lung cancer in patients who are at high risk for the disease.
PURPOSE: Randomized clinical trial to compare the effectiveness of a spiral CT scan with that of a chest x-ray in detecting lung cancer in patients who are at high risk for the disease.
Looking for future studies?
Notify MeKey information
Conditions
Age range
55 year–74 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
About this study
OBJECTIVES: I. Compare the efficacy of screening spiral CT scan and screening chest x-ray in detecting lung cancer in current or former smokers at high risk for lung cancer.
OUTLINE: This is a randomized, multicenter study of lung cancer screening. Patients are randomized to one of two screening arms. Arm I: Patients undergo one spiral CT scan. Arm II: Patients undergo one chest x-ray. Patients and their primary care physicians are notified of test results within 3 weeks of the exam.
PROJECTED ACCRUAL: A total of 3,000 participants (1,500 per screening arm) will be accrued for this study at six screening centers (500 per center) by October 31, 2000.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS: See General Eligibility Criteria
PATIENT CHARACTERISTICS: Age: 55 to 74 Patients with a cigarette smoking history of at least 30 pack-years Current smoker OR Smoker who has quit smoking within the past 10 years No known prior history of lung cancer
PRIOR CONCURRENT THERAPY: No concurrent therapy for any cancer except nonmelanomatous skin cancer No prior removal of any portion of the lungs No concurrent participation in other cancer screening trial, including PLCO No concurrent participation in a primary cancer prevention trial other than a smoking cessation trial
Treatment and study plan
comparison of screening methods
ProcedureComputed Tomography
ProcedureRadiography
Procedurestudy of high risk factors
ProcedureSponsors and collaborators
Lead sponsor
National Cancer Institute (NCI)
Nih
Registry information
Important dates
- Study start
- 2000
- Study completion
- 2002
- First posted
- Jun 9, 2004
- Registry last updated
- May 5, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Trial of NanoPac Intratumoral Injection in Lung Cancer
NCT04314895
Bronchial Neoplasms, Carcinoma, Bronchogenic
Gainesville, Florida, United States
View Trial DetailsA Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
NCT02922764
Bronchial Neoplasms, Carcinoma, Bronchogenic
Tucson, Arizona, United States
View Trial DetailsA Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
NCT05337163
Actinomycetales Infections, Acute Bronchitis
Guangzhou, Guangdong, China
View Trial DetailsReveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:
NCT04836975
Bronchial Neoplasms, Carcinoma, Bronchogenic
Riyadh, Saudi Arabia
View Trial Details